The prevalence of bladder pain syndrome/interstitial cystitis in Italy: The importance of a national registry

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the last 30 years, Interstitial Cystitis (IC) diagnostic and etiopathogenetic criteria, as well as its taxonomy, have been strongly debated. Not only internationally, but also within the National Institute of Health (NIH) and especially the National Institute of Diabetes of the Digestive Tract of and Kidney Disease (NIDDK), many changes have occurred. It is a common opinion that IC epidemiology data are highly inconsistent because of the lack of a shared definition and a valid diagnostic marker. In 2001, the Italian government recognized this condition as a rare disease, thanks to hard work of Patients’ Organization (Associazione Italiana Cistite interstiziale-AICI). The Higher Institute of Health (ISS) was given the task to put in place a National Registry of Rare Diseases (NRRD) as well as the Regional Registries (RR) within the framework of a very complex network consisting of Reference Centers and experts, to collect quality data. The RR are the NRRD infrastructure, an important tool to carry out the network’s tracking, the rare diseases surveillance and the data flow analysis where patients receive diagnose and treatments. It will be analyzed the network, NRRD and the data performed in the last 15 years (Courtesy of ISS).

Cite

CITATION STYLE

APA

Nasta, L. (2017). The prevalence of bladder pain syndrome/interstitial cystitis in Italy: The importance of a national registry. In Bladder Pain Syndrome - An Evolution (pp. 27–32). Springer International Publishing. https://doi.org/10.1007/978-3-319-61449-6_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free